¼¼°èÀÇ ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Subcutaneous Drug Delivery Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1649467
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,439,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,266,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀåÀº 2025³â 417¾ï 400¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 6.26%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 565¾ï 300¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀåÀº ÁÖ·Î °í±Þ Àúħ½À ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°üÁúȯ(CVD)°ú ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½Â°ú ´õºÒ¾î »ý¹°ÇÐÀû ¾àÁ¦ °³¹ßÀÇ Áøº¸°¡ ÇコÄɾîÀÇ Àü¸ÁÀ» ¹Ù²Ù°í ÀÖ½À´Ï´Ù.

ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

´ç´¢º´ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±â¾÷Àº ÷´Ü ÇÇÇÏ ¾à¹°Àü´Þ ±â±â¸¦ µµÀÔÇϱâ À§ÇÑ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ Çõ½ÅÇϰí ÀÌÇàÇß½À´Ï´Ù. ÇÁ¸®Çʵå ÁÖ»ç±â, ƯÈ÷ Àν¶¸° ÀÚµ¿ ÁÖ»ç±â´Â ȯÀÚ°¡ ÃÖ¼ÒÇÑÀÇ ºÒÄè°¨À¸·Î È¿À²ÀûÀ¸·Î ¾à¹°À» ÀÚü Åõ¿©ÇÒ ¼ö ÀÖ°Ô ÇØÁÖ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î µîÀåÇß½À´Ï´Ù. IDF ´ç´¢º´ ¾ÆÆ²¶ó½º(2021³â)¿¡ µû¸£¸é, 20¼¼¿¡¼­ 79¼¼ÀÇ ¼ºÀÎ Áß 10.5%°¡ ´ç´¢º´À» ¾Î°í ÀÖÀ¸¸ç, Àý¹Ý °¡±îÀÌ ÀÚ½ÅÀÇ Áõ»óÀ» ¾ËÁö ¸øÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø¿¡ µû¸£¸é 2045³â±îÁö ¼ºÀÎ 8¸í Áß 1¸íÀÌ ´ç´¢º´ÀÌ µÇ¾î 46% Áõ°¡ÇÑ 7¾ï 8,300¸¸ ¸íÀÌ µÉ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æ¿ìÀÇ 90% ÀÌ»óÀÌ 2Çü ´ç´¢º´À̸ç, »çȸ°æÁ¦Àû, Àα¸Åë°èÀû, ȯ°æÀû, À¯ÀüÀû ¿äÀÎÀÌ ±× ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀåÀÇ Áö¸®Àû Àü¸Á :

°Ô´Ù°¡, Áö¿ªÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¾öû³­ ÅõÀÚ´Â ±â±âÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´, ÀÚ°¡¸é¿ªÁúȯ, ½ÉÇ÷°üÁúȯ µî ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁö´Â °ÍÀº ºÏ¹ÌÀÇ ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æ°ü¸®¼¾ÅÍ(CDC)ÀÇ Ãß°è¿¡ µû¸£¸é 2022³â¿¡´Â ¹Ì±¹¿¡¼­ ¾à 2,970¸¸ ¸í(Àα¸ÀÇ ¾à 8.9%)ÀÌ ´ç´¢º´¿¡ °É·È½À´Ï´Ù. Àν¶¸° Ææ, ÀÚµ¿ ÁÖ»ç±â, ¿þ¾î·¯ºí ÁÖ»ç±â µî ÇÇÇÏ ¾à¹°Àü´ÞÀ» À§ÇØ ¼³°èµÈ ±â±â´Â ¸¸¼º Áúȯ¿¡ ÇʼöÀûÀÎ °ü¸® µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â Áö¼ÓÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô º¸´Ù ÆíÀǼº, Á¤È®¼º ¹× »ç¿ë ÆíÀǼºÀ» Á¦°øÇÕ´Ï´Ù. ¿ä¾àÇϸé ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀåÀº ¸¸¼º Áúȯ °ü¸®ÀÇ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ´ç´¢º´ ¹× ½ÉÇ÷°ü Áúȯ µî Áúº´ÀÇ À¯º´·ü Áõ°¡, ¾à¹° ±â±â ±â¼úÀÇ Áøº¸, ÁöÁöÀûÀÎ ±ÔÁ¦ ȯ°æ, ƯÈ÷ ºÏ¹ÌÀÇ Áß¿äÇÑ Áö¿ª Á¤¼¼º° °³Ã´ µî ÀÌ È®´ëµÇ´Â ½ÃÀå »óȲÀ» °­È­ÇÏ´Â ¿äÀο¡ ÀÇÇØ Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸ÀÔÇÏ´Â ÀÌÀ¯

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀåÀº ´ÙÀ½°ú °°ÀÌ ¼¼ºÐÈ­µË´Ï´Ù.

Á¦Ç° À¯Çüº°

¿ëµµº°

ÃÖÁ¾ »ç¿ëÀÚº°

Áö¿ªº°

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦6Àå ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀå : ¿ëµµº°

Á¦7Àå ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦8Àå ÇÇÇÏ ¾à¹°Àü´Þ ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ȯ°æ ¹× ºÐ¼®

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The subcutaneous drug delivery market is estimated at USD41.704 billion in 2025 and is anticipated to grow at a CAGR of 6.26% during the forecast period and reach USD56.503 billion in 2030.

The market for subcutaneous drug delivery devices is experiencing rapid growth, primarily fueled by the increasing demand for advanced minimally invasive solutions. The rising prevalence of chronic conditions such as cardiovascular disease (CVD) and diabetes, along with advancements in biological drug development, is transforming the healthcare landscape.

Drivers of the Subcutaneous Drug Delivery Market:

The increasing diabetes patient population has prompted companies to innovate and implement strategic initiatives to introduce advanced subcutaneous drug delivery devices. Prefilled syringes, particularly insulin autoinjectors, have emerged as transformative solutions that allow patients to self-administer medications efficiently and with minimal discomfort. According to the IDF Diabetes Atlas (2021), 10.5% of adults aged 20 to 79 years have diabetes, with nearly half unaware of their condition. Projections indicate that by 2045, 1 in 8 adults will be living with diabetes, marking a 46% increase to an estimated 783 million individuals. Over 90% of these cases are type 2 diabetes, driven by socio-economic, demographic, environmental, and genetic factors.

Geographical Outlook of the Subcutaneous Drug Delivery Market:

Additionally, significant investments in regional research and development are driving continuous innovation in subcutaneous drug delivery devices. The high prevalence of chronic conditions such as diabetes, autoimmune disorders, and cardiovascular diseases serves as a primary market driver in North America. According to estimates from the Centers for Disease Control and Prevention (CDC), approximately 29.7 million people in the United States-about 8.9% of the population-had diabetes in 2022. This underscores the importance of effective and accessible treatment options.Devices designed for subcutaneous drug delivery-such as insulin pens, auto-injectors, and wearable injectors-are becoming essential management tools for chronic conditions. These devices offer greater convenience, precision, and user-friendliness for patients requiring ongoing treatments. With an aging population and an increasing prevalence of chronic diseases, the market for these devices is expected to expand further, solidifying North America's position as a leader in the global subcutaneous drug delivery market.In summary, the subcutaneous drug delivery market is poised for substantial growth driven by rising demand for innovative solutions in chronic disease management, increasing prevalence of conditions like diabetes and cardiovascular diseases, advancements in drug-device technology, supportive regulatory environments, and significant geographical developments-particularly within North America-that enhance this expanding market landscape.

Reasons for buying this report:-

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Subcutaneous Drug Delivery Market has been segmented as following:

By Product Type:

By Application:

By End-Users:

By Geography:

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. SUBCUTANEOUS DRUG DELIVERY MARKET BY PRODUCT TYPE

6. SUBCUTANEOUS DRUG DELIVERY MARKET BY APPLICATION

7. SUBCUTANEOUS DRUG DELIVERY MARKET BY END-USERS

8. SUBCUTANEOUS DRUG DELIVERY MARKET BY GEOGRAPHY

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

10. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â